A National Survey of the Prevalence, Incidence, Primary Care Burden and Treatment of Heart Failure in Scotland

N. Murphy; Colin Richard Simpson; F. A. McAlister; Sandra Stewart; K. McIntyre; M. Kirkpatrick; J. Chalmers; A. Redpath; S. Capewell; J. J. V. McMurray

doi:10.1136/hrt.2003.029553

A National Survey of the Prevalence, Incidence, Primary Care Burden and Treatment of Heart Failure in Scotland

N. Murphy, Colin Richard Simpson, F. A. McAlister, Sandra Stewart, K. McIntyre, M. Kirkpatrick, J. Chalmers, A. Redpath, S. Capewell, J. J. V. McMurray

Research output: Contribution to journal › Article › peer-review

55 Citations (Scopus)

Abstract

Objective: To examine the epidemiology, primary care burden, and treatment of heart failure in Scotland, UK.

Design: Cross sectional data from primary care practices participating in the Scottish continuous morbidity recording scheme between 1 April 1999 and 31 March 2000.

Setting: 53 primary care practices ( 307 741 patients).

Subjects: 2186 adult patients with heart failure.

Results: The prevalence of heart failure in Scotland was 7.1 in 1000, increasing with age to 90.1 in 1000 among patients greater than or equal to 85 years. The incidence of heart failure was 2.0 in 1000, increasing with age to 22.4 in 1000 among patients greater than or equal to 85 years. For older patients, consultation rates for heart failure equalled or exceeded those for angina and hypertension. Respiratory tract infection was the most common comorbidity leading to consultation. Among men, 23% were prescribed a beta blocker, 11% spironolactone, and 46% an angiotensin converting enzyme inhibitor. The corresponding figures for women were 20% (p = 0.29 versus men), 7% (p = 0.02), and 34% (p < 0.001). Among patients, 75 years 26% were prescribed a β blocker, 11% spironolactone, and 50% an angiotensin converting enzyme inhibitor. The corresponding figures for patients &GE; 75 years were 19% (p = 0.04 versus patients < 75), 7% (p = 0.04), and 33% (p < 0.001).

Conclusions: Heart failure is a common condition, especially with advancing age. In the elderly, the community burden of heart failure is at least as great as that of angina or hypertension. The high rate of concomitant respiratory tract infection emphasises the need for strategies to immunise patients with heart failure against influenza and pneumococcal infection. Drugs proven to improve survival in heart failure are used less frequently for elderly patients and women.

Original language	English
Pages (from-to)	1129-1136
Number of pages	7
Journal	Heart
Volume	90
DOIs	https://doi.org/10.1136/hrt.2003.029553
Publication status	Published - 2004

Keywords

VENTRICULAR SYSTOLIC DYSFUNCTION
GENERAL-PRACTICE
ELDERLY-PATIENTS
COMMUNITY
POPULATION
MANAGEMENT
INFLUENZA
ETIOLOGY
EPIDEMIOLOGY
VACCINATION

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/hrt.2003.029553

Cite this

@article{3a0ea1d1362a46abb7d272536cac9d9f,

title = "A National Survey of the Prevalence, Incidence, Primary Care Burden and Treatment of Heart Failure in Scotland",

abstract = "Objective: To examine the epidemiology, primary care burden, and treatment of heart failure in Scotland, UK.Design: Cross sectional data from primary care practices participating in the Scottish continuous morbidity recording scheme between 1 April 1999 and 31 March 2000.Setting: 53 primary care practices ( 307 741 patients).Subjects: 2186 adult patients with heart failure.Results: The prevalence of heart failure in Scotland was 7.1 in 1000, increasing with age to 90.1 in 1000 among patients greater than or equal to 85 years. The incidence of heart failure was 2.0 in 1000, increasing with age to 22.4 in 1000 among patients greater than or equal to 85 years. For older patients, consultation rates for heart failure equalled or exceeded those for angina and hypertension. Respiratory tract infection was the most common comorbidity leading to consultation. Among men, 23% were prescribed a beta blocker, 11% spironolactone, and 46% an angiotensin converting enzyme inhibitor. The corresponding figures for women were 20% (p = 0.29 versus men), 7% (p = 0.02), and 34% (p < 0.001). Among patients, 75 years 26% were prescribed a β blocker, 11% spironolactone, and 50% an angiotensin converting enzyme inhibitor. The corresponding figures for patients &GE; 75 years were 19% (p = 0.04 versus patients < 75), 7% (p = 0.04), and 33% (p < 0.001).Conclusions: Heart failure is a common condition, especially with advancing age. In the elderly, the community burden of heart failure is at least as great as that of angina or hypertension. The high rate of concomitant respiratory tract infection emphasises the need for strategies to immunise patients with heart failure against influenza and pneumococcal infection. Drugs proven to improve survival in heart failure are used less frequently for elderly patients and women.",

keywords = "VENTRICULAR SYSTOLIC DYSFUNCTION, GENERAL-PRACTICE, ELDERLY-PATIENTS, COMMUNITY, POPULATION, MANAGEMENT, INFLUENZA, ETIOLOGY, EPIDEMIOLOGY, VACCINATION",

author = "N. Murphy and Simpson, {Colin Richard} and McAlister, {F. A.} and Sandra Stewart and K. McIntyre and M. Kirkpatrick and J. Chalmers and A. Redpath and S. Capewell and McMurray, {J. J. V.}",

year = "2004",

doi = "10.1136/hrt.2003.029553",

language = "English",

volume = "90",

pages = "1129--1136",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - A National Survey of the Prevalence, Incidence, Primary Care Burden and Treatment of Heart Failure in Scotland

AU - Murphy, N.

AU - Simpson, Colin Richard

AU - McAlister, F. A.

AU - Stewart, Sandra

AU - McIntyre, K.

AU - Kirkpatrick, M.

AU - Chalmers, J.

AU - Redpath, A.

AU - Capewell, S.

AU - McMurray, J. J. V.

PY - 2004

Y1 - 2004

N2 - Objective: To examine the epidemiology, primary care burden, and treatment of heart failure in Scotland, UK.Design: Cross sectional data from primary care practices participating in the Scottish continuous morbidity recording scheme between 1 April 1999 and 31 March 2000.Setting: 53 primary care practices ( 307 741 patients).Subjects: 2186 adult patients with heart failure.Results: The prevalence of heart failure in Scotland was 7.1 in 1000, increasing with age to 90.1 in 1000 among patients greater than or equal to 85 years. The incidence of heart failure was 2.0 in 1000, increasing with age to 22.4 in 1000 among patients greater than or equal to 85 years. For older patients, consultation rates for heart failure equalled or exceeded those for angina and hypertension. Respiratory tract infection was the most common comorbidity leading to consultation. Among men, 23% were prescribed a beta blocker, 11% spironolactone, and 46% an angiotensin converting enzyme inhibitor. The corresponding figures for women were 20% (p = 0.29 versus men), 7% (p = 0.02), and 34% (p < 0.001). Among patients, 75 years 26% were prescribed a β blocker, 11% spironolactone, and 50% an angiotensin converting enzyme inhibitor. The corresponding figures for patients &GE; 75 years were 19% (p = 0.04 versus patients < 75), 7% (p = 0.04), and 33% (p < 0.001).Conclusions: Heart failure is a common condition, especially with advancing age. In the elderly, the community burden of heart failure is at least as great as that of angina or hypertension. The high rate of concomitant respiratory tract infection emphasises the need for strategies to immunise patients with heart failure against influenza and pneumococcal infection. Drugs proven to improve survival in heart failure are used less frequently for elderly patients and women.

AB - Objective: To examine the epidemiology, primary care burden, and treatment of heart failure in Scotland, UK.Design: Cross sectional data from primary care practices participating in the Scottish continuous morbidity recording scheme between 1 April 1999 and 31 March 2000.Setting: 53 primary care practices ( 307 741 patients).Subjects: 2186 adult patients with heart failure.Results: The prevalence of heart failure in Scotland was 7.1 in 1000, increasing with age to 90.1 in 1000 among patients greater than or equal to 85 years. The incidence of heart failure was 2.0 in 1000, increasing with age to 22.4 in 1000 among patients greater than or equal to 85 years. For older patients, consultation rates for heart failure equalled or exceeded those for angina and hypertension. Respiratory tract infection was the most common comorbidity leading to consultation. Among men, 23% were prescribed a beta blocker, 11% spironolactone, and 46% an angiotensin converting enzyme inhibitor. The corresponding figures for women were 20% (p = 0.29 versus men), 7% (p = 0.02), and 34% (p < 0.001). Among patients, 75 years 26% were prescribed a β blocker, 11% spironolactone, and 50% an angiotensin converting enzyme inhibitor. The corresponding figures for patients &GE; 75 years were 19% (p = 0.04 versus patients < 75), 7% (p = 0.04), and 33% (p < 0.001).Conclusions: Heart failure is a common condition, especially with advancing age. In the elderly, the community burden of heart failure is at least as great as that of angina or hypertension. The high rate of concomitant respiratory tract infection emphasises the need for strategies to immunise patients with heart failure against influenza and pneumococcal infection. Drugs proven to improve survival in heart failure are used less frequently for elderly patients and women.

KW - VENTRICULAR SYSTOLIC DYSFUNCTION

KW - GENERAL-PRACTICE

KW - ELDERLY-PATIENTS

KW - COMMUNITY

KW - POPULATION

KW - MANAGEMENT

KW - INFLUENZA

KW - ETIOLOGY

KW - EPIDEMIOLOGY

KW - VACCINATION

U2 - 10.1136/hrt.2003.029553

DO - 10.1136/hrt.2003.029553

M3 - Article

SN - 1355-6037

VL - 90

SP - 1129

EP - 1136

JO - Heart

JF - Heart

ER -

A National Survey of the Prevalence, Incidence, Primary Care Burden and Treatment of Heart Failure in Scotland

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this